Great Point Partners as of Sept. 30, 2023
Portfolio Holdings for Great Point Partners
Great Point Partners holds 40 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Urogen Pharma (URGN) | 6.7 | $37M | 2.6M | 14.01 | |
| Alpine Immune Sciences (ALPN) | 6.4 | $35M | 3.1M | 11.45 | |
| Sarepta Therapeutics (SRPT) | 5.7 | $32M | 260k | 121.22 | |
| Pliant Therapeutics (PLRX) | 5.5 | $30M | 1.8M | 17.34 | |
| Vaxcyte (PCVX) | 4.9 | $27M | 531k | 50.98 | |
| Ultragenyx Pharmaceutical (RARE) | 4.7 | $26M | 727k | 35.65 | |
| Alkermes SHS (ALKS) | 4.5 | $25M | 875k | 28.01 | |
| Rapt Therapeutics (RAPT) | 4.4 | $24M | 1.5M | 16.62 | |
| Zura Bio Class A Ord Shs (ZURA) | 4.0 | $22M | 3.3M | 6.60 | |
| Evolus (EOLS) | 3.6 | $20M | 2.2M | 9.14 | |
| Point Biopharma Global | 3.5 | $19M | 2.9M | 6.67 | |
| Cytokinetics Com New (CYTK) | 3.2 | $18M | 600k | 29.46 | |
| Xenon Pharmaceuticals (XENE) | 3.1 | $17M | 500k | 34.16 | |
| Aclaris Therapeutics (ACRS) | 3.0 | $16M | 2.4M | 6.85 | |
| Anaptysbio Inc Common (ANAB) | 2.9 | $16M | 894k | 17.96 | |
| Immunocore Hldgs Ads (IMCR) | 2.8 | $15M | 291k | 51.90 | |
| Aerovate Therapeutics (AVTE) | 2.7 | $15M | 1.1M | 13.57 | |
| Intra Cellular Therapies (ITCI) | 2.1 | $12M | 225k | 52.09 | |
| Ptc Therapeutics I (PTCT) | 2.0 | $11M | 500k | 22.41 | |
| Replimune Group (REPL) | 2.0 | $11M | 639k | 17.11 | |
| Optinose (OPTN) | 2.0 | $11M | 8.8M | 1.23 | |
| Amicus Therapeutics (FOLD) | 1.9 | $10M | 857k | 12.16 | |
| Arcellx Common Stock (ACLX) | 1.9 | $10M | 288k | 35.88 | |
| Karuna Therapeutics Ord | 1.9 | $10M | 61k | 169.09 | |
| Akero Therapeutics (AKRO) | 1.8 | $10M | 199k | 50.58 | |
| Insmed Com Par $.01 (INSM) | 1.8 | $10M | 395k | 25.25 | |
| Reneo Pharmaceuticals (RPHM) | 1.6 | $8.9M | 1.2M | 7.62 | |
| Apogee Therapeutics (APGE) | 1.6 | $8.5M | 400k | 21.30 | |
| Gossamer Bio (GOSS) | 0.9 | $5.2M | 6.2M | 0.83 | |
| Igm Biosciences (IGMS) | 0.9 | $5.1M | 615k | 8.35 | |
| Heron Therapeutics (HRTX) | 0.9 | $4.9M | 4.7M | 1.03 | |
| Cerevel Therapeutics Hldng I (CERE) | 0.9 | $4.7M | 215k | 21.83 | |
| Acumen Pharmaceuticals (ABOS) | 0.8 | $4.5M | 1.1M | 4.15 | |
| Generation Bio (GBIO) | 0.7 | $3.9M | 1.0M | 3.79 | |
| Mirati Therapeutics | 0.7 | $3.8M | 86k | 43.56 | |
| Terns Pharmaceuticals (TERN) | 0.6 | $3.2M | 646k | 5.03 | |
| Talaris Therapeutics | 0.5 | $2.8M | 1.0M | 2.81 | |
| Gracell Biotechnologies Sponsored Ads | 0.3 | $1.7M | 580k | 2.88 | |
| Solid Biosciences Com New (SLDB) | 0.2 | $1.1M | 450k | 2.52 | |
| Ambrx Biopharma Sponsored Ads Call Option | 0.2 | $1.1M | 98k | 11.50 |
